What is GLP-4 Metatrutide?
GLP-4 Metatrutide is a catalog formulation containing GLP-3 RT, PEG-MGF.
Catalog-listed components
Composition is taken from the current DA listing. Confirm the exact ratio, excipients and identity for the selected material.
Custom DA blend of GLP-3 RT and PEG-MGF; the catalog does not establish a distinct fourth receptor target or a new single molecule.
What the research covers
This formulation combines the catalog-listed components below. Evidence on the individual components does not establish the effects, compatibility or stability of the complete mixture.
The studies linked here may concern individual ingredients or related molecules. They do not establish that this named formulation has been tested as a whole.
What remains uncertain
Component studies cannot validate this finished formulation. The identity, composition, stability and experimental behavior of the mixture require their own documentation.
The evidence label describes the linked research, not the suitability of a catalog product for use in people. Formulation, identity, purity, and measured content must be assessed separately.
Sources & studies
GLP-3 RT catalog record ↗
Component reference: GLP-3 RT. This source does not validate the finished blend.
Cloning and characterization of an IGF-1 isoform expressed in skeletal muscle subjected to stretch. ↗
Component reference: PEG-MGF. This source does not validate the finished blend.
Different roles of the IGF-I Ec peptide (MGF) and mature IGF-I in myoblast proliferation and differentiation. ↗
Component reference: PEG-MGF. This source does not validate the finished blend.
Read the full paper for its design, controls and limitations. A source link is not a claim that its tested material matches a DA formulation.
Catalog formats & documentation
Formats grouped by compound identity. Availability and batch documentation remain on Disguised Alpha.
Original DA reference: GLP-4 Metatrutide research guide ↗